-
Signature
-
/s/ James Dillon, As Attorney-in-Fact
-
Stock symbol
-
MRNA
-
Transactions as of
-
Oct 5, 2023
-
Transactions value $
-
-$292,953
-
Form type
-
4
-
Date filed
-
10/10/2023, 04:51 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MRNA |
Common Stock |
Options Exercise |
|
+5.81K |
|
|
5.81K |
Oct 5, 2023 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$293K |
-2.86K |
-49.19% |
$102.50 |
2.95K |
Oct 6, 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MRNA |
Restricted Stock Units |
Options Exercise |
$0 |
-5.81K |
-25% |
$0.00 |
17.4K |
Oct 5, 2023 |
Common Stock |
5.81K |
|
Direct |
F1, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: